Clinical Trial Update: Retrospective Chart Review of Valstar

View source ↗

Summary

A completed retrospective chart review of Valstar for carcinoma in situ of the bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma in Situ of the Bladder

Drugs mentioned

• VALSTAR (valrubicin)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Carcinoma in Situ of Bladder | Status: COMPLETED